Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection

Journal of Immunology

Volumn 164, Issue 11, 2000, Pages 5890-5893

  Monteforte, Gina M ^a   Takeda, Kiyoshi ^b   Rodriguez Sosa, Miriam ^a   Akira, Shizuo ^b   David, John R ^a   Satoskar, Abhay R ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LYMPH NODE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TH1 CELL;

EID: 0034040798     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.11.5890     Document Type: Article

References (25)

1. Alexander, J., A. R. Satoskar, and D. G. Russell. 1999. Leishmania species: models of intracellular parasitism. J. Cell Sci. 112:2993.
2. Reiner, S. L. and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
3. + T lymphocytes in vivo during healing and progressive cutaneous leishmaniasis. Proc. Natl. Acad. Sci. USA 88:7011.
4. Skeiky, Y. A. W., M. Kennedy, D. Kaufman, M. M. Borges, J. A. Guderian, J. K. Scholler, P. J. Ovendale, K. S. Picha, P. J. Morrissey, P. J. Grabstein, et al. 1998. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. J. Immunol. 161:6171.
5. Heinzel, F. P., M. D. Sadick, B. J. Holaday, R. L. Coffman, and R. M. Locksley. 1989. Reciprocal expression of interferon-γ or interleukin 4 during the resolution or progression of murine leishmaniasis. J. Exp. Med. 169:59.
6. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al. 1995. Cloning of new cytokine that induces IFN-γ production by T cells. Nature 378:88.
7. Sugawara, I., H. Yamada, H. Kaneko, S. Mizuno, K. Takeda, and S. Akira 1999. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect. Immun. 67:2585.
8. Bohn, E., A. Sing, R. Zumbihl, C. Bielfeldt, H. Okamura, M. Kurimoto, J. Heesemann, and I. B. Autenrieth. 1998. IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol. 160:219.
9. Fujioka, N., R. Akazawa, K. Ohashi, M. Fujii, M. Ikeda, and M. Kurimoto. 1999. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J. Virol. 71:2401.
10. Kawakami, K., M. H. Qureshi, T. Zhang, H. Okamura, M. Kurimoto, and A. Saito. 1997. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ production. J. Immunol. 159: 5528.
11. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383.
12. Maltner, F. J., J. Magram, P. Ferrante, K. Launois, R. Padova, M. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin 12 are susceptible to infection with Leishmania major and mount a polarized Th2 response. Eur. J. Immunol. 26:1553.
13. Manner, F., K. DiPadova, and G. Alber. 1997. Interleukin 12 is indispensable for protective immunity against Leishmania major infection. Infect. Immun. 65:4378.
14. Yoshimoto, T., K. Ohkusu, H. Okamura, and K. Nakanishi. 1998. Induction of host resistance to Leishmania major by IL-12 and IL-18 in vivo IL-12 treatment upregulates IL-18 receptor expression or T cells. FASEB J. 12:A1068.
15. Satoskar, A. R., L. M. Stamm, X. Zhang, A. A. Satoskar, M. Okano, C. Terhorst, J. R. David, and B. Wang. 1999. Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection. J. Immunol. 162: 6747.
16. Stamm, L. M., A. A. Satoskar, S. Ghosh, J. R. David, and A, R. Satoskar. 1999. STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis. Eur. J. Immunol. 29:2524.
17. Heinzel, F. P., D. S. Schoenhaut, R. M. Reeko, L. E. Rosser, and M. K. Gatley. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 179:447.
18. Sypek, J. P., C. L. Chung, S. E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1505.
19. Scharton-Kersten, T., L. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 64:5129.
20. Dinarello, C. A., D. Novick, A. J. Puren, G. Fantuzzi, L. Shapiro, H. Muhl, D.-Y. Yoon, L. L. Reznikov, S.-H. Kim, and M. Rubinstein. 1998. Overview of interleukin-18: more than an interferon-γ inducing factor. J. Leukocyte Biol. 63:658.
21. Ushio S., M. Namba, T. Okura, K. Hattori, Y. Nukada, K. Akita, F. Tanabe, K. Konishi, M. Micallef, M. Fujii, et al. 1996. Cloning of the cDNA for human IFN-γ inducing factor, expression in Escheriichia Coli, and studies on the biologic activities of the protein. J. Immunol. 156:4274.
22. - cells. J. Immunol. 160:4783.
23. Ahn, H.-J., S. Maruo, M. Tomura, J. Mu, T. Hamaoka, K. Nakanishi, S. Clark, M. Kurimoto, H. Okamura, and H. Fujiwara. 1997. A mechanism underlying synergy between IL-12 and IFN-γ-inducing factor in enhanced production of IFN-γ. J. Immunol. 159:2125.
24. Wei, X., B. P. Leung, W. Niedbala, D. Piedrafita, G. Feng, M. Sweet, L. Dobbie, A. J. H. Smith, and F. Y. Liew. 1999. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. J. Immunol. 163:2821.
25. Xu, D., W. L. Chan, B. P. Leung, D. Hunter, K. Schulz, R. W. Carter, I. B. McInnes, J. H Robinson, and F. Y. Liew. 1998. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J. Exp. Med. 188:1485.